Search hospitals > Wisconsin > Rhinelander
Ascension Saint Mary's Hospital
Claim this profileRhinelander, Wisconsin 54501
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
106 reported clinical trials
5 medical researchers
Summary
Ascension Saint Mary's Hospital is a medical facility located in Rhinelander, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Ascension Saint Mary's Hospital is involved with conducting 106 clinical trials across 246 conditions. There are 5 research doctors associated with this hospital, such as Andrew J. Huang, Christopher S. Platta, Jonathan S. Treisman, and Francis J. Cuevas.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 positive
PR positive
Top PIs
Andrew J. HuangAspirus Regional Cancer Center1 year of reported clinical research
Expert in Cancer
Expert in Lung Cancer
59 reported clinical trials
135 drugs studied
Christopher S. PlattaAspirus Regional Cancer Center6 years of reported clinical research
Studies Prostate Cancer
Studies Cancer
12 reported clinical trials
38 drugs studied
Jonathan S. TreismanAscension Saint Elizabeth Hospital4 years of reported clinical research
Studies Cancer
Studies Lung Cancer
12 reported clinical trials
27 drugs studied
Francis J. CuevasAscension Southeast Wisconsin Hospital - Elmbrook Campus7 years of reported clinical research
Studies Colorectal Cancer
Studies Cancer
11 reported clinical trials
24 drugs studied
Clinical Trials running at Ascension Saint Mary's Hospital
Breast Cancer
Lung Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Cancer
Squamous Cell Carcinoma
Prostate Adenocarcinoma
Small Cell Lung Cancer
Colon Cancer
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ascension Saint Mary's Hospital?
Ascension Saint Mary's Hospital is a medical facility located in Rhinelander, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Ascension Saint Mary's Hospital is involved with conducting 106 clinical trials across 246 conditions. There are 5 research doctors associated with this hospital, such as Andrew J. Huang, Christopher S. Platta, Jonathan S. Treisman, and Francis J. Cuevas.